Osteoporosis medication to preserve muscle in seniors
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests whether an osteoporosis medication can help preserve muscle strength in older adults who live in senior facilities. It's for people age 65+ with fragile bones or low bone density who are at risk for falls and fractures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You live in a nursing home, assisted living facility, or senior community.
- You have osteoporosis or low bone mass with a high risk of fracture.
- You are not currently on certain osteoporosis medications, or have not taken them for more than a year in the last 2 years.
- You do not have a life expectancy of less than 1 year or a recent serious illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether denosumab, a medication that strengthens bones, can also improve muscle strength and insulin sensitivity in postmenopausal women with type 2 diabetes who take metformin.
This Phase 2 study tests whether zoledronic acid or denosumab can prevent bone thinning in critically ill adults after staying in the ICU. It may help reduce the risk of future bone fractures if your body is at higher risk during and after critical illness.
This study from Bursa City Hospital looks at how age affects the response to common osteoporosis medicines (denosumab or bisphosphonates) using bone density scans (DXA). It aims to see if older adults respond differently to treatment.
This trial tests if denosumab, a drug that strengthens bones, can help people with type 2 diabetes who have a high risk of breaking a bone. It is for patients who have had diabetes for a long time or have certain complications.
This study compares two medicines (ibandronate and zoledronic acid) to see which one works better at keeping bones strong after stopping denosumab (Prolia). It's for postmenopausal women with mild to moderate bone thinning.
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.